focus -WSS

focus

author：focus 2025-09-28 23:29:19 - browse：2728

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Kellogg’s is going to war over Mexico’s nutrition label rules

WSS

How the drug

Abortion policy in the spotlight at Republican debate

Prescription digital therapeutics are key to pharma’s future

STAT wants to know your pick for a great summer read or listen

'Screen and refer' systems are hurting patients

Hubble vs. James Webb telescope images: See the difference

entertainment

focus

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Hospital at home shows how to bring innovation to health care

Malaria cases in Florida and Texas: Here’s what you need to know

Study: Spinal cord stimulation helps patients with paralysis walk again

Cancer drug shortages should be causing more outrage

CDC says it’s too soon to assess risk posed by Covid subvariant

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Use doctors trained outside the U.S. to ease the physician shortage

ChatGPT in medicine: STAT answers readers' burning questions

CDC says it’s too soon to assess risk posed by Covid subvariant

focus

Fatty liver disease was alleviated by Lilly’s ‘triple

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

How Robert F. Kennedy Jr. distorted vaccine science

Study: Spinal cord stimulation helps patients with paralysis walk again

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

explore

hotspot

Wikipedia

explore